West Pharmaceutical Services Share Holder Equity 2010-2024 | WST
West Pharmaceutical Services share holder equity from 2010 to 2024. Share holder equity can be defined as the sum of preferred and common equity items
- West Pharmaceutical Services share holder equity for the quarter ending September 30, 2024 was $2.752B, a 4.05% decline year-over-year.
- West Pharmaceutical Services share holder equity for 2023 was $2.881B, a 7.3% increase from 2022.
- West Pharmaceutical Services share holder equity for 2022 was $2.685B, a 14.97% increase from 2021.
- West Pharmaceutical Services share holder equity for 2021 was $2.335B, a 25.93% increase from 2020.
West Pharmaceutical Services Annual Share Holder Equity
(Millions of US $) |
| 2023 |
$2,881 |
| 2022 |
$2,685 |
| 2021 |
$2,335 |
| 2020 |
$1,855 |
| 2019 |
$1,573 |
| 2018 |
$1,396 |
| 2017 |
$1,280 |
| 2016 |
$1,118 |
| 2015 |
$1,024 |
| 2014 |
$957 |
| 2013 |
$906 |
| 2012 |
$729 |
| 2011 |
$655 |
| 2010 |
$626 |
| 2009 |
$579 |
West Pharmaceutical Services Quarterly Share Holder Equity
(Millions of US $) |
| 2024-09-30 |
$2,752 |
| 2024-06-30 |
$2,577 |
| 2024-03-31 |
$2,681 |
| 2023-12-31 |
$2,881 |
| 2023-09-30 |
$2,868 |
| 2023-06-30 |
$2,747 |
| 2023-03-31 |
$2,776 |
| 2022-12-31 |
$2,685 |
| 2022-09-30 |
$2,471 |
| 2022-06-30 |
$2,424 |
| 2022-03-31 |
$2,326 |
| 2021-12-31 |
$2,335 |
| 2021-09-30 |
$2,202 |
| 2021-06-30 |
$2,033 |
| 2021-03-31 |
$1,829 |
| 2020-12-31 |
$1,855 |
| 2020-09-30 |
$1,719 |
| 2020-06-30 |
$1,606 |
| 2020-03-31 |
$1,490 |
| 2019-12-31 |
$1,573 |
| 2019-09-30 |
$1,488 |
| 2019-06-30 |
$1,445 |
| 2019-03-31 |
$1,370 |
| 2018-12-31 |
$1,396 |
| 2018-09-30 |
$1,352 |
| 2018-06-30 |
$1,282 |
| 2018-03-31 |
$1,305 |
| 2017-12-31 |
$1,280 |
| 2017-09-30 |
$1,317 |
| 2017-06-30 |
$1,242 |
| 2017-03-31 |
$1,169 |
| 2016-12-31 |
$1,118 |
| 2016-09-30 |
$1,142 |
| 2016-06-30 |
$1,109 |
| 2016-03-31 |
$1,074 |
| 2015-12-31 |
$1,024 |
| 2015-09-30 |
$995 |
| 2015-06-30 |
$989 |
| 2015-03-31 |
$941 |
| 2014-12-31 |
$957 |
| 2014-09-30 |
$970 |
| 2014-06-30 |
$973 |
| 2014-03-31 |
$935 |
| 2013-12-31 |
$906 |
| 2013-09-30 |
$837 |
| 2013-06-30 |
$784 |
| 2013-03-31 |
$746 |
| 2012-12-31 |
$729 |
| 2012-09-30 |
$717 |
| 2012-06-30 |
$680 |
| 2012-03-31 |
$695 |
| 2011-12-31 |
$655 |
| 2011-09-30 |
$691 |
| 2011-06-30 |
$696 |
| 2011-03-31 |
$663 |
| 2010-12-31 |
$626 |
| 2010-09-30 |
$632 |
| 2010-06-30 |
$571 |
| 2010-03-31 |
$580 |
| 2009-12-31 |
$579 |
| 2009-09-30 |
$566 |
| 2009-06-30 |
$533 |
| 2009-03-31 |
$489 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical & Dental Supplies |
$23.854B |
$2.950B |
|
West Pharmaceutical Services Inc. is a leading global manufacturer with respect to design and production of technologically advanced, high-quality, integrated containment and delivery systems for injectable drugs and healthcare products. The Exton, PA-based company designs and produces these medical products in the Americas, Europe, the Middle East, Africa and the Asia Pacific. Its primary objective is to deliver quality products that cater to the exact product specifications and quality standards that customers expect and need. West Pharmaceutical operates through two segments: Proprietary Products and Contract-Manufactured Products.
|
